Trasturel 440 mg Injection Trastuzumab

Trasturel 440 mg Injection contains trastuzumab, a monoclonal antibody used in the treatment of HER2-positive cancers, including breast cancer and gastric cancer. It is a targeted therapy that specifically attacks cancer cells overexpressing the HER2 protein, helping slow or stop tumor growth.

This medicine is widely used in oncology protocols and plays a critical role in improving outcomes in patients with HER2-positive cancers.

How it works

Trastuzumab binds to the HER2 receptors on cancer cells, blocking their growth signals and marking them for destruction by the immune system. This targeted approach helps reduce damage to normal cells compared to traditional chemotherapy.

• HER2-positive breast cancer
• HER2-positive metastatic breast cancer
• HER2-positive gastric (stomach) cancer

Benefits

• Targeted therapy against HER2 cancer cells
• Helps slow or stop tumor growth
• Improves treatment outcomes in combination therapy
• Widely used in standard oncology protocols

Administered as an intravenous infusion under medical supervision. Dosage and frequency depend on the treatment protocol and patient condition.